Amalgamated Bank’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.44M | Sell |
|
|||||
|
2025
Q1 | $1.49M | Buy |
|
|||||
|
2024
Q4 | $1.82M | Sell |
|
|||||
|
2024
Q3 | $1.99M | Sell |
|
|||||
|
2024
Q2 | $2.69M | Buy |
|
|||||
|
2024
Q1 | $2.9M | Sell |
|
|||||
|
2023
Q4 | $3.75M | Sell |
|
|||||
|
2023
Q3 | $3.39M | Buy |
|
|||||
|
2023
Q2 | $3.29M | Sell |
|
|||||
|
2023
Q1 | $3.73M | Sell |
|
|||||
|
2022
Q4 | $4.24M | Buy |
|
|||||
|
2022
Q3 | $3.77M | Buy |
|
|||||
|
2022
Q2 | $4.04M | Sell |
|
|||||
|
2022
Q1 | $5.41M | Buy |
|
|||||
|
2021
Q4 | $7.08M | Sell |
|
|||||
|
2021
Q3 | $7.84M | Sell |
|
|||||
|
2021
Q2 | $7.25M | Buy |
|
|||||
|
2021
Q1 | $2.64M | Sell |
|
|||||
|
2020
Q4 | $2.47M | Buy |
|
|||||
|
2020
Q3 | $2.23M | Sell |
|
|||||
|
2020
Q2 | $1.76M | Sell |
|
|||||
|
2020
Q1 | $1.65M | Sell |
|
|||||
|
2019
Q4 | $2.03M | Buy |
|
|||||
|
2019
Q3 | $1.65M | Buy |
|
|||||
|
2019
Q2 | $1.57M | Buy |
|
|||||
|
2019
Q1 | $1.56M | Buy |
|
|||||
|
2018
Q4 | $1.2M | Buy |
|
|||||
|
2018
Q3 | $1.03M | Sell |
|
|||||
|
2018
Q2 | $1.23M | Buy |
|
|||||
|
2018
Q1 | $1.13M | Buy |
|
|||||
|
2017
Q4 | $1.08M | Buy |
|
|||||
|
2017
Q3 | $1.01M | Sell |
|
|||||
|
2017
Q2 | $956K | Buy |
|
|||||
|
2017
Q1 | $676K | Sell |
|
|||||
|
2016
Q4 | $687K | Buy |
|
|||||
|
2016
Q3 | $679K | Sell |
|
|||||
|
2016
Q2 | $679K | Buy |
|
|||||
|
2016
Q1 | $442K | Buy |
|
|||||
|
2015
Q4 | $432K | Sell |
|
|||||
|
2015
Q3 | $365K | Buy |
|
|||||
|
2015
Q2 | $399K | Buy |
|
|||||
|
2015
Q1 | $273K | Buy |
|
|||||
|
2014
Q4 | $207K | Buy |
|